These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12018666)

  • 1. A rational approach to diagnosis and treatment of intermittent claudication.
    Fernandez BB
    Am J Med Sci; 2002 May; 323(5):244-51. PubMed ID: 12018666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent claudication: effective medical management of a common circulatory problem.
    Beebe HG
    Am J Cardiol; 2001 Jun; 87(12A):14D-18D. PubMed ID: 11434895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with intermittent claudication.
    Olin JW
    Int J Clin Pract; 2002 Nov; 56(9):687-93. PubMed ID: 12469984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of intermittent claudication with pentoxifylline and cilostazol.
    Tjon JA; Riemann LE
    Am J Health Syst Pharm; 2001 Mar; 58(6):485-93; quiz 494-6. PubMed ID: 11286146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based symptom relief of intermittent claudication: efficacy and safety of cilostazol.
    Donnelly R
    Diabetes Obes Metab; 2002 Mar; 4 Suppl 2():S20-5. PubMed ID: 12180354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of cilostazol and other therapies for intermittent claudication.
    Dawson DL
    Am J Cardiol; 2001 Jun; 87(12A):19D-27D. PubMed ID: 11434896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of peripheral arterial disease.
    Creager MA
    Cardiol Rev; 2001; 9(4):238-45. PubMed ID: 11405904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established and evolving medical therapies for claudication in patients with peripheral arterial disease.
    Regensteiner JG; Stewart KJ
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):604-10. PubMed ID: 17063165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cilostazol in the treatment of intermittent claudication.
    Barnett AH; Bradbury AW; Brittenden J; Crichton B; Donnelly R; Homer-Vanniasinkam S; Mikhailidis DP; Stansby G
    Curr Med Res Opin; 2004 Oct; 20(10):1661-70. PubMed ID: 15462700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary medical management of peripheral arterial disease: a focus on risk reduction and symptom relief for intermittent claudication.
    Agrawal K; Eberhardt RT
    Cardiol Clin; 2015 Feb; 33(1):111-37. PubMed ID: 25439335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for peripheral arterial disease: emerging therapeutic options.
    Jaff MR
    Angiology; 2002; 53(6):627-33. PubMed ID: 12463615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of intermittent claudication: cilostazol.
    Collins P; Brittenden J
    Hosp Med; 2004 Aug; 65(8):466-70. PubMed ID: 15330347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.
    Guest JF; Davie AM; Clegg JP
    Curr Med Res Opin; 2005 Jun; 21(6):817-26. PubMed ID: 15969881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003748. PubMed ID: 17253494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cilostazol: treatment of intermittent claudication.
    Reilly MP; Mohler ER
    Ann Pharmacother; 2001 Jan; 35(1):48-56. PubMed ID: 11197586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent claudication: magnitude of the problem, patient evaluation, and therapeutic strategies.
    Schmieder FA; Comerota AJ
    Am J Cardiol; 2001 Jun; 87(12A):3D-13D. PubMed ID: 11434894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of withdrawal of drugs treating intermittent claudication.
    Dawson DL; DeMaioribus CA; Hagino RT; Light JT; Bradley DV; Britt KE; Charles BE
    Am J Surg; 1999 Aug; 178(2):141-6. PubMed ID: 10487267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current management of intermittent claudication: the role of pharmacological and nonpharmacological symptom-directed therapies.
    Mangiafico RA; Fiore CE
    Curr Vasc Pharmacol; 2009 Jul; 7(3):394-413. PubMed ID: 19601864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of cilostazol and pentoxifylline on vascular endothelial growth factor in patients with intermittent claudication.
    Lee TM; Su SF; Tsai CH; Lee YT; Wang SS
    Clin Sci (Lond); 2001 Sep; 101(3):305-11. PubMed ID: 11524048
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.